UBS analyst Joshua Spector maintains Nutrien (NYSE:NTR) with a Buy and lowers the price target from $110 to $103.
UBS Maintains Buy on Nutrien, Lowers Price Target to $103
UBS analyst Joshua Spector maintains Nutrien (NYSE:NTR) with a Buy and lowers the price target from $110 to $103.
Related Posts
Toll Brothers Beat Earnings, But Are The Numbers Foggy? Here’s What Analysts Say
Toll Brothers Inc (NYSE: TOL) issued an upbeat earnings report Tuesday — the company's strongest in history.
What 35 Analyst Ratings Have To Say About SolarEdge Technologies
SolarEdge Technologies (NASDAQ:SEDG) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Microsoft Announces New AI Solutions For Microsoft Cloud For Nonprofit: A Game-changer For Fundraising And Volunteer Engagement
Microsoft Corp. on Monday is announcing a suite of new AI solutions and improvements to Microsoft Cloud for Nonprofit that are designed to transform the nonprofit industry and how fundraisers engage with